• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GSS
Click for more information
2.17% 67.5¢

GENETIC SIGNATURES LIMITED - Announcements

Market Cap $155.4M  ! watchlist Created with Sketch. Add to my watchlist

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
GSS Date of 2016 AGM-GSS.AX 23/09/16
GSS Change in substantial holding-GSS.AX 19/09/16
GSS Change in substantial holding-GSS.AX 19/09/16
GSS SPP booklet and acceptance form-GSS.AX 12/09/16
GSS Notice of Extraordinary General Meeting/Proxy Form-GSS.AX 12/09/16
GSS GSS issues first tranche of $14m share placement-GSS.AX 12/09/16
GSS Cleansing Notice-GSS.AX 08/09/16
GSS Appendix 3B-GSS.AX 08/09/16
GSS Capital Raising Investor Presentation-GSS.AX 02/09/16
GSS Completion of $14m capital raising-GSS.AX PRICE SENSITIVE02/09/16
GSS Trading Halt-GSS.AX PRICE SENSITIVE31/08/16
GSS Preliminary Final Report-GSS.AX PRICE SENSITIVE30/08/16
GSS Appendix 3B and ASIC form 484-GSS.AX 28/08/16
GSS Appendix 3B and ASIC form 484-GSS.AX 26/08/16
GSS Non-Deal Roadshow Presentation-GSS.AX 22/07/16
GSS Appendix 4C - quarterly-GSS.AX PRICE SENSITIVE21/07/16
GSS ASIC form 484-GSS.AX 15/07/16
GSS Appendix 3B-GSS.AX 15/07/16
GSS ASIC form 484-GSS.AX 14/07/16
GSS Appendix 3B-GSS.AX 13/07/16
GSS Appendix 3B-GSS.AX 30/06/16
GSS UCLA to launch Genetic Signatures technology-GSS.AX PRICE SENSITIVE24/06/16
GSS UCLA to launch Genetic Signatures technology-GSS.AX PRICE SENSITIVE24/06/16
GSS GSS launches Analyte Specific Reagents in US-GSS.AX PRICE SENSITIVE17/06/16
GSS Change of Director's Interest Notice-GSS.AX 10/05/16
GSS Change of Director's Interest Notice-GSS.AX 04/05/16
GSS Appendix 4C - quarterly-GSS.AX PRICE SENSITIVE28/04/16
GSS Change of Director's Interest Notice-GSS.AX 14/04/16
GSS Appendix 3B-GSS.AX 14/04/16
GSS Change of Director's Interest Notice30/03/16
GSS End of voluntary escrow period11/03/16
GSS Updated Share Trading Policy07/03/16
GSS Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE26/02/16
GSS Amended Appendix 4C - quarterly29/01/16
GSS Appendix 4C - quarterlyPRICE SENSITIVE29/01/16
GSS Appendix 3B19/11/15
GSS Results of Meeting09/11/15
GSS 2015 AGM CEO Presentation09/11/15
GSS Chairman's Address to Shareholders09/11/15
GSS Collaboration with UCLAPRICE SENSITIVE06/11/15
GSS Appendix 4C - quarterlyPRICE SENSITIVE30/10/15
GSS Presentation to Australian Microcap Investment Conference20/10/15
GSS Appendix 4G - Corporate Governance Statement09/10/15
GSS Notice of Annual General Meeting/Proxy Form09/10/15
GSS 2015 Annual Report09/10/15
GSS Resignation of Director01/10/15
GSS Change of registered office address29/09/15
GSS Date of Annual General Meeting28/09/15
GSS Non-Deal Roadshow Presentation24/09/15
GSS GSS launches North America commercial operations22/09/15
GSS Director Appointment15/09/15
GSS Amended Appendix 4E and Audited Financial Report27/08/15
GSS Appendix 4E and Audited Financial ReportPRICE SENSITIVE27/08/15
GSS Final Director's Interest Notice26/08/15
GSS Management changes21/08/15
GSS Genetic Signatures expands into multiple European countriesPRICE SENSITIVE13/08/15
GSS Appendix 4C - quarterlyPRICE SENSITIVE30/07/15
GSS GSS FDA Clinical Concentrator ListingPRICE SENSITIVE22/07/15
GSS Bioshares 2015 Presentation20/07/15
GSS Non-Deal Roadshow Presentation25/05/15
GSS Change of registry address15/05/15
GSS Appendix 4C - quarterlyPRICE SENSITIVE27/04/15
GSS GSS Respiratory InstallationPRICE SENSITIVE10/04/15
GSS Becoming a substantial holder08/04/15
GSS Initial Director's Interest Notice08/04/15
GSS GSS Listing Press Release01/04/15
GSS Share Trading Policy30/03/15
GSS Corporate Governance Statement30/03/15
GSS Employee Share Ownership Plan30/03/15
GSS Financial Report for the year ended 30 June 201430/03/15
GSS Financial Report for the year ended 30 June 201330/03/15
GSS Financial Report for the year ended 30 June 201230/03/15
GSS Constitution30/03/15
GSS Supplementary Prospectus30/03/15
GSS Prospectus30/03/15
GSS Top 20 shareholders list30/03/15
GSS Distribution Schedule30/03/15
GSS Information Form and Checklist30/03/15
GSS Appendix 1A30/03/15
GSS Pre-quotation disclosure30/03/15
GSS Admission to the Official ListPRICE SENSITIVE30/03/15
GSS ASX Notice - Admission and Commencement of Quotation30/03/15
GSS Date of 2016 AGM-GSS.AX
23/09/16
GSS Change in substantial holding-GSS.AX
19/09/16
GSS Change in substantial holding-GSS.AX
19/09/16
GSS SPP booklet and acceptance form-GSS.AX
12/09/16
GSS Notice of Extraordinary General Meeting/Proxy Form-GSS.AX
12/09/16
GSS GSS issues first tranche of $14m share placement-GSS.AX
12/09/16
GSS Cleansing Notice-GSS.AX
08/09/16
GSS Appendix 3B-GSS.AX
08/09/16
GSS Capital Raising Investor Presentation-GSS.AX
02/09/16
GSS Completion of $14m capital raising-GSS.AX
02/09/16PRICE SENSITIVE
GSS Trading Halt-GSS.AX
31/08/16PRICE SENSITIVE
GSS Preliminary Final Report-GSS.AX
30/08/16PRICE SENSITIVE
GSS Appendix 3B and ASIC form 484-GSS.AX
28/08/16
GSS Appendix 3B and ASIC form 484-GSS.AX
26/08/16
GSS Non-Deal Roadshow Presentation-GSS.AX
22/07/16
GSS Appendix 4C - quarterly-GSS.AX
21/07/16PRICE SENSITIVE
GSS ASIC form 484-GSS.AX
15/07/16
GSS Appendix 3B-GSS.AX
15/07/16
GSS ASIC form 484-GSS.AX
14/07/16
GSS Appendix 3B-GSS.AX
13/07/16
GSS Appendix 3B-GSS.AX
30/06/16
GSS UCLA to launch Genetic Signatures technology-GSS.AX
24/06/16PRICE SENSITIVE
GSS UCLA to launch Genetic Signatures technology-GSS.AX
24/06/16PRICE SENSITIVE
GSS GSS launches Analyte Specific Reagents in US-GSS.AX
17/06/16PRICE SENSITIVE
GSS Change of Director's Interest Notice-GSS.AX
10/05/16
GSS Change of Director's Interest Notice-GSS.AX
04/05/16
GSS Appendix 4C - quarterly-GSS.AX
28/04/16PRICE SENSITIVE
GSS Change of Director's Interest Notice-GSS.AX
14/04/16
GSS Appendix 3B-GSS.AX
14/04/16
GSS Change of Director's Interest Notice
30/03/16
GSS End of voluntary escrow period
11/03/16
GSS Updated Share Trading Policy
07/03/16
GSS Appendix 4D - Half Yearly Report and Accounts
26/02/16PRICE SENSITIVE
GSS Amended Appendix 4C - quarterly
29/01/16
GSS Appendix 4C - quarterly
29/01/16PRICE SENSITIVE
GSS Appendix 3B
19/11/15
GSS Results of Meeting
09/11/15
GSS 2015 AGM CEO Presentation
09/11/15
GSS Chairman's Address to Shareholders
09/11/15
GSS Collaboration with UCLA
06/11/15PRICE SENSITIVE
GSS Appendix 4C - quarterly
30/10/15PRICE SENSITIVE
GSS Presentation to Australian Microcap Investment Conference
20/10/15
GSS Appendix 4G - Corporate Governance Statement
09/10/15
GSS Notice of Annual General Meeting/Proxy Form
09/10/15
GSS 2015 Annual Report
09/10/15
GSS Resignation of Director
01/10/15
GSS Change of registered office address
29/09/15
GSS Date of Annual General Meeting
28/09/15
GSS Non-Deal Roadshow Presentation
24/09/15
GSS GSS launches North America commercial operations
22/09/15
GSS Director Appointment
15/09/15
GSS Amended Appendix 4E and Audited Financial Report
27/08/15
GSS Appendix 4E and Audited Financial Report
27/08/15PRICE SENSITIVE
GSS Final Director's Interest Notice
26/08/15
GSS Management changes
21/08/15
GSS Genetic Signatures expands into multiple European countries
13/08/15PRICE SENSITIVE
GSS Appendix 4C - quarterly
30/07/15PRICE SENSITIVE
GSS GSS FDA Clinical Concentrator Listing
22/07/15PRICE SENSITIVE
GSS Bioshares 2015 Presentation
20/07/15
GSS Non-Deal Roadshow Presentation
25/05/15
GSS Change of registry address
15/05/15
GSS Appendix 4C - quarterly
27/04/15PRICE SENSITIVE
GSS GSS Respiratory Installation
10/04/15PRICE SENSITIVE
GSS Becoming a substantial holder
08/04/15
GSS Initial Director's Interest Notice
08/04/15
GSS GSS Listing Press Release
01/04/15
GSS Share Trading Policy
30/03/15
GSS Corporate Governance Statement
30/03/15
GSS Employee Share Ownership Plan
30/03/15
GSS Financial Report for the year ended 30 June 2014
30/03/15
GSS Financial Report for the year ended 30 June 2013
30/03/15
GSS Financial Report for the year ended 30 June 2012
30/03/15
GSS Constitution
30/03/15
GSS Supplementary Prospectus
30/03/15
GSS Prospectus
30/03/15
GSS Top 20 shareholders list
30/03/15
GSS Distribution Schedule
30/03/15
GSS Information Form and Checklist
30/03/15
GSS Appendix 1A
30/03/15
GSS Pre-quotation disclosure
30/03/15
GSS Admission to the Official List
30/03/15PRICE SENSITIVE
GSS ASX Notice - Admission and Commencement of Quotation
30/03/15
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
67.5¢ 		Change
-0.015(2.17%) 		Mkt cap ! $155.4M
Open High Low Value Volume
68.5¢ 68.5¢ 67.5¢ $8.27K 12.21K

Buyers (Bids)

No. Vol. Price($)
2 34322 67.5¢
 

Sellers (Offers)

Price($) Vol. No.
68.5¢ 7757 1
View Market Depth
Last trade - 13.57pm 29/11/2024 (20 minute delay) ?
Last
67.5¢ 		  Change
-0.015 ( 2.05 %)
Open High Low Volume
68.5¢ 68.5¢ 67.5¢ 8294
Last updated 15.20pm 29/11/2024 ?
GSS (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor The ASX200 has been really flirting with the 8,500pts mark this week, notching an intraweek ATH of 8,476pts.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.